Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gachon University Gil Medical Center
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
non resectable colorectal adenocarcinoma.
disease progression during or within 6months after treatment with irinotecan and oxaliplatin contaning regimens.
estimated life expectancy of more than 3 months.
ECOG status 2 or lower
You may not be if
other tumor type than adenoarcinoma.
presence or history of CNS metastasis.
evidence of gastrointestinal bleeding.
Clareo Health | A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.
